Celiac disease and the gluten-free diet

Pediatric Health

Volumn 4, Issue 3, 2010, Pages 321-328

  Martin, Suzanne ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Celiac disease; Chronic diarrhea; Gluten free diet; Malignancy

Indexed keywords

DEAMIDATED GLIADIN PEPTIDE; DEAMIDATED GLIADIN PEPTIDE ANTIBODY; ENDOMYSIUM ANTIBODY; GLIADIN; GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PEPTIDE ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN BINDING; AUTOIMMUNE DISEASE; BONE DENSITY; CANCER RISK; CELIAC DISEASE; CLINICAL FEATURE; DERMATITIS HERPETIFORMIS; DIFFERENTIAL DIAGNOSIS; DOWN SYNDROME; EARLY DIAGNOSIS; ENTERITIS; ENVIRONMENTAL FACTOR; GASTROINTESTINAL SYMPTOM; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; MALABSORPTION; NUTRITIONAL DEFICIENCY; OAT; PATHOGENESIS; PATIENT COMPLIANCE; PREVALENCE; PROTEIN BINDING; REVIEW; RISK FACTOR; SEROLOGY;

EID: 77953267923     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/phe.10.22     Document Type: Review

References (39)

1. Catassi C, Kryszak D, Jouis-Jacques O et al.: Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am. J. Gastroenterol. 102, 1454-1460 (2007).
2. Rewers M: Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 128, S47-S51 (2005).
3. Green P, Cellier C: Celiac disease. N. Engl. J. Med. 357, 1731-1743 (2007).
4. Kagnoff MF: Overview and pathogenesis of celiac disease. Gastroenterology 128, S10-S18 (2005).
5. Haines M, Anderson R, Gibson P: Systematic review: the evidence base for long-term management of coeliac disease. Aliment. Pharmacol. Ther. 28, 1042-1066 (2008).
6. Branski D, Fasano A, Troncone R: Latest developments in the pathogenesis and treatment of celiac disease. J. Pediatr. 149, 295-300 (2006).
7. NIH: NIH consensus on celiac disease. Gastroenterology 128, S52-S59 (2004).
8. Martin S: Against the grain: an overview of celiac disease. J. Am. Acad. Nurse Pract. 20, 243-250 (2008).
9. Fasano A: Clinical presentation of celiac disease in the pediatric population. Gastroenterology 128, S68-S73 (2005).
10. Fasano A: How to handle a clinical chameleon. N. Engl. J. Med. 248(25), 2568-2570 (2003).
11. Green P: The many faces of celiac disease in the adult population. Gastroenterology 128, S74-S78 (2005).
12. Fasano A, Berti I, Gerarduzzi T et al.: Prevalence of celiac disease in at-risk and not-at-risk groups in the United States. Arch. Int. Med. 163, 286-292 (2003).
13. Murray JA: Celiac disease in patients with an affected member, Type 1 diabetes, iron-deficiency, or osteoporosis. Gastroenterology 128, S52-S56 (2005).
14. Hill I, Fasano A, Schwart R, Counts D, Glock M, Harvath K: The prevalence of celiac disease in at-risk groups of children in the United States. J. Pediatr. 136(1), 86-90 (2000).
15. Annibale B, Lahnew E, Chistolina A et al.: Endoscopic evaluation of the upper gastrointestinal tract is worthwhile in premenopausal women with iron-deficiency anaemia irrespective of menstrual flow. Scand. J. Gastroenterol. 33, 239-245 (2003).
16. Catassi C, Bearzi I, Holmes G: Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128, S79-S86 (2005).
17. Zone JJ: Skin manifestations of celiac disease. Gastroenterology 128, S87-S91 (2005).
18. Dewar D, Ciclitra J: Clinical features and diagnosis of celiac disease. Gastroenterology 128, S19-S24 (2005).
19. Rostom A, Murray J, Kagnoff M: American Gastroenterological Association (AGA) institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131(6), 1981-2002 (2006).
20. Hill I: What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 128, S25-S32 (2005).
21. Lewis N, Scott B: Systematic review: the use of serology to exclude or diagnosis coeliac disease: a comparison of the endomysial and tissue transglutaminase antibody tests. Aliment. Pharmacol. Ther. 24, 47-54 (2006).
22. Prause C, Richter T, Koletzko S et al.: New developments in the serodiagnosis of childhood celiac disease. Ann. NY Acad. Sci. 1173, 28-35 (2009).
23. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition: Guidelines for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 40, 1-19 (2005).
24. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK: Revised criteria for diagnosis of coeliac disease. Report of Working Group of Paediatric Society of Gastroenterology and Nutrition. Arch. Dis. Child. 65, 909-911 (1990).
25. Janatuinen EK, Pikkarainen PH, Kemppainen TR et al.: A comparison of diets with and without oats in adults with celiac disease. N. Engl. J. Med. 333(16), 1033-1037 (1995).
26. Srinivasan U, Leonard N, Jones E et al.: Absence of oats toxicity in adult coeliac disease. BMJ 313, 1300-1301 (1996).
27. Stursrud S, Olsson M, Arvidsson Lenner R et al. Adult coeliac patients do tolerate large amounts of oats. Eur. J. Clin. Nutr. 57(1), 163-169 (2003).
28. Peräaho M, Collin P, Kaukinen K, Kekkonen L, Miettinen S, Mäki M: Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis. J. Am. Diet. Assoc. 104(7), 1148-1150 (2004).
29. Troncone R, Auricchio R, Granata V: Issues related to gluten-free diet in coeliac disease. Curr. Opin. Clin. Nutr. Metab. Care 11, 329-333 (2008).
30. Case S: The gluten-free diet: how to provide effective education and resources. Gastroenterology 128, S128-S134 (2005).
31. Silvester JA, Rashid M: Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines. Can. J. Gastroenterol. 21(9), 557-564 (2007).
32. Pietzak M: Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology 128, S135-S141 (2005).
33. Liu E, Li M, Emery L et al.: Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J. Pediatr. Grastroenterol. Nutr. 45(3), 293-300 (2007).
34. Basso D, Guaiso G, Fogar P et al.: Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin. Chem. 55, 150-157 (2009).
35. Volta U, Granito A, Fiorini E et al.: Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig. Dis. Sci. 53, 1582-1588 (2008).
36. Corroa G, Corazza GR, Bagnardi V et al.: Mortality in patients with celiac disease and their relatives: a cohort study. Lancet 358(9279), 356-361 (2001).
37. Goddard C, Gillet H: Complications of coeliac disease: are all patients at risk? Postgrad. Med. J. 82, 705-712 (2006).
38. Ventura A, Magazzu G, Greco L: Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 117, 297-303 (1999).
39. Van Koppen E, Schweizer J, Csizmadia C et al.: Long-term health and quality-of-life consequences of mass screening for childhood celiac disease: a 10-year follow-up study. Pediatrics 123, 582-588 (2009).